Přejít k obsahu
Merck

Characterization of nicergoline polymorphs crystallized in several organic solvents.

Journal of pharmaceutical sciences (2011-01-22)
Ledjan Malaj, Roberta Censi, Doretta Capsoni, Luca Pellegrino, Marcella Bini, Stefania Ferrari, Roberto Gobetto, Vincenzo Massarotti, Piera Di Martino
ANOTACE

Nicergoline (NIC), a poorly water-soluble semisynthetic ergot derivative, was crystallized from several organic solvents, obtaining two different polymorphic forms, the triclinic form I and the orthorhombic form II. NIC samples were then characterized by several techniques such as (13)C cross-polarization magic angle spinning solid-state spectroscopy, room-temperature and high-temperature X-ray powder diffraction, differential scanning calorimetry, and by analysis of weight loss, solvent content, powder density, morphology, and particle size. Solubility and intrinsic dissolution rates determined for the two polymorphic forms in water and hydrochloride solutions (HCl 0.1 N) were always higher for form II than for form I, which is actually the form used for the industrial preparation of NIC medicinal products. Preformulation studies might encourage industry for the evaluation of polymorph II, as it is more suitable for pharmaceutical applications. Results in drug delivery, as well as those obtained by the above-mentioned techniques, and the application of Burger-Ramberger's rules make it possible to conclude that there is a thermodynamic relation of monotropy between the two polymorphs. This last assumption may help formulators in predicting the relative stability of the two forms.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Supelco
Nicergoline, analytical standard, for drug analysis
Nicergoline for peak identification, European Pharmacopoeia (EP) Reference Standard
Nicergoline for system suitability, European Pharmacopoeia (EP) Reference Standard